The Supreme Court has the power to decide on the accessibility of the abortion pill, mifepristone, which has been a significant part of medication abortions in the US. The safety of mifepristone is well-established, with data showing it is safer than common prescription drugs and has lower risks compared to procedural abortion and childbirth.
Key Points
Supreme Court's conservative supermajority could impact the accessibility of medication abortion.
Mifepristone accounts for a significant portion of US abortions.
Data supports the safety and effectiveness of mifepristone in medication abortions.
Pros
Mifepristone, a key pill in medication abortions, has been accessible and widely used since its FDA approval in 2000.
Data shows that mifepristone is safer than some common, low-risk prescription drugs like penicillin and Viagra.
Medication abortion using mifepristone has a lower risk of serious complications compared to procedural abortion and childbirth.
Cons
Changes in regulations could potentially limit access to medication abortion and mifepristone.
A federal judge in Texas has ruled to suspend the FDA's approval of mifepristone, pending the Supreme Court's decision.